Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. by Talbot, D, Ranson, M, Davies, J, Lahn, M, Callies, S, André, V, Kadam, S, Burgess, M, Slapak, C, Olsen, A, McHugh, P, de Bono, J, Matthews, J, Saleem, A, Price, P